Sign in
4/A

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000636

CHIEF FINANCIAL OFFICER gave up 1,733 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WEAVER GREGORY L CHIEF FINANCIAL OFFICER 2020-01-30 Option exercise +5,000 9,500 D: show line 1 in the form
WEAVER GREGORY L CHIEF FINANCIAL OFFICER 2020-01-30 Shares withheld for taxes −1,733 $3.91 $6,776 7,767 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
WEAVER GREGORY L CHIEF FINANCIAL OFFICER 2020-01-30 Option exercise · Restricted Stock Units −5,000 15,000 D: show line 3 in the form
Loading xslF345X03/form4a-03042020_020302.xml…